Cantor Fitzgerald Forecasts Higher Earnings for MannKind
MannKind Co. (NASDAQ:MNKD – Free Report) – Cantor Fitzgerald raised their FY2024 earnings per share estimates for MannKind in a research report issued on Wednesday, February 26th. Cantor Fitzgerald analyst O. Brayer now forecasts that the biopharmaceutical company will post earnings of $0.10 per share for the year, up from their previous estimate of $0.08. […]
MannKind Co. (NASDAQ:MNKD – Free Report) – Cantor Fitzgerald raised their FY2024 earnings per share estimates for MannKind in a research report issued on Wednesday, February 26th. Cantor Fitzgerald analyst O. Brayer now forecasts that the biopharmaceutical company will post earnings of $0.10 per share for the year, up from their previous estimate of $0.08. […]
